For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240424:nRSX7699La&default-theme=true
RNS Number : 7699L Ironveld PLC 24 April 2024
This announcement contains inside information
Ironveld Plc
("Ironveld" or the "Company")
Working Capital Facility
Ironveld plc ("Ironveld" or the "Company"), the AIM-traded mining development
company, is pleased to confirm that it has today entered into a further
working capital loan facility agreement ("Facility Agreement") with Tracarta
Limited ("Tracarta"), in which John Wardle, Executive Chairman of the Company,
has a beneficial interest. The Facility Agreement enables the Company to draw
down up to £125,000 on equivalent terms to the existing loan facilities with
Tracarta (see announcement released on 2 February 2024) and has a term of six
months.
The funds drawn down under the Facility Agreement will be used to strengthen
the Company's working capital position. As previously notified, the Company
remains in discussions regarding a direct institutional funding transaction,
which is currently expected to close in H1 2024 and, if concluded, will enable
Ironveld to invest in all Group operations, including transition to production
of high purity iron powders. As indicated in the Company's interim results
announcement (released on 28 March 2024), the Board is assessing the Company's
current funding requirements which will likely require the Company to raise
additional capital, potentially through the issue of new equity.
The Facility Agreement has the following key terms:
Facility Amount: £125,000
Term: 6 months
Interest: 11% per annum
Fee: 2.5%
Repayment and Conversion: Repayment of any funds drawn down plus interest immediately upon receipt of
funds drawn down from any replacement institutional debt facility or
conversion at the issue price in the event of any future equity placing during
the loan term
Warrants: None
Related Party Transaction
John Wardle has a beneficial interest in Tracarta and, as such, the provision
of the facility by Tracarta constitutes a related party transaction pursuant
to Rule 13 of the AIM Rules for Companies. The Company's independent Directors
(being Giles Clarke, Nick Harrison, Peter Cox and Malebo Ratlhagane) consider,
having consulted with the Company's nominated adviser, Cavendish, that the
terms of the Facility Agreement are fair and reasonable insofar as the
Company's shareholders are concerned.
For further information, please contact:
Ironveld plc c/o BlytheRay
Dr John Wardle, Executive Chairman +44 20 7138 3204
Cavendish Capital Markets Ltd (Nomad and Joint Broker) +44 20 7220 0500
Derrick Lee / Adam Rae
Turner Pope (Joint Broker) +44 20 3657 0050
Andrew Thacker/James Pope
BlytheRay +44 20 7138 3204
Tim Blythe / Megan Ray
NOTES TO EDITORS
Ironveld (IRON.LN) is the owner of Mining Rights over approximately 28
kilometres of outcropping Bushveld magnetite with a SAMREC compliant ore
resource of some 56 million tons of ore grading 1.12% V2O5, 68.6% Fe2O3 and
14.7% TiO2.
In 2022, Ironveld agreed to acquire and refurbish a smelter facility in
Rustenburg, South Africa, in which it can process its magnetite ore into the
marketable products of high purity iron, titanium slag and vanadium slag. This
transaction became unconditional in March 2023.
Ironveld is an AIM traded company. For further information on Ironveld please
refer to www.ironveld.com (http://www.ironveld.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGRBCGDSCXDDGSX